Prostate Cancer: RO7656594 Treatment Study

We are evaluating a new medication for patients with advanced or metastatic prostate cancer. The study focuses on its safety and how the body handles the drug.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Institut Paoli-Calmettes
Unité de Soins Ambulatoires
Marseille, France
Centre Leon Berard
Service d’Oncologie Médicale
Meyzieu, France
Institut Gustave Roussy
Service d’Oncologie Médicale
Villejuif, France

Sponsor: Genentech Inc.
Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.